C07F 9/65611
Containing the ring system [image cpc-sch-c07f-1003.gif] optionally with an additional double bond
Official title: {containing the ring system [IMAGE cpc-sch-C07F-1003.gif] (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. penicillins and analogs}
C07F9/65611 (Containing the ring system [image cpc-sch-c07f-1003.gif] optionally with an additional double bond) appears on 68 US grants and 6 published applications in this corpus.
Search patents in C07F- Granted patents
- 68
- Published applications
- 6
- Assignees
- 23
- Inventors
- 90
- Latest grant
- 29 Oct 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 4 | 0 |
| 1978 | 5 | 0 |
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 4 | 0 |
| 1982 | 1 | 0 |
| 1983 | 4 | 0 |
| 1984 | 2 | 0 |
| 1985 | 4 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 3 | 0 |
| 1989 | 2 | 0 |
| 1990 | 4 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 3 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 2 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 1 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Condensed cyclic compound and organic light-emitting device including the same29 Oct 2019US 10,461,263 B2Samsung Display Co., Ltd.
- Process for the preparation of carbapenem using cabapenem intermediates and recovery of cabapenem20 May 2014US 8,729,260 B2Savior Lifetec Corporation
- Crystallization method for intermediates of carbapenem antibiotics10 Jan 2012US 8,093,378 B2Kaneka Corporation
- Carbapenem compound5 Apr 2011US 7,919,616 B2Nippon Soda Co., Ltd.
- Intermediate for carbapenem compound for oral administration and process for producing the same26 May 2009US 7,538,212 B2Kaneka Corporation
- Condensed cyclic compound and organic light-emitting device including the same15 Mar 2018US 2018/0076396 A1Samsung Display Co., Ltd.
- Process for the preparation of carbapenem using cabapenem intermediates and recovery of cabapenem24 Nov 2011US 2011/0288290 A1Savior Lifetec Corporation
- Carbapenem Compound4 Jun 2009US 2009/0143574 A1Nippon Soda Co., Ltd.
- Crystallization Method for Intermediates of Carbapenem Antibiotics7 May 2009US 2009/0118496 A1Kaneka Corporation
- Novel intermediate for carbapenem compound for oral administration and process for producing the same9 Nov 2006US 2006/0252929 A1Kaneka Corporation
Most cited
By later US patents
- Targeted drug delivery via phosphonate derivatives55US 5,177,064 AUniversity of Florida · 1993
- Targeted drug delivery via phosphonate derivatives53US 5,413,996 AUniversity of Florida · 1995
- Antibacterial agents, and 4-thio azetidinone intermediates32US 4,272,437 ABristol-Myers Company · 1981
- B-lactam compounds29US 4,943,569 ASumitomo Pharmaceuticals Company, Limited · 1990
- .beta.-lactam compounds24US 4,933,333 ASumitomo Pharmaceuticals Company, Limited · 1990